Some U.S. health regulators who review medical devices and tobacco products for safety and efficacy are struggling to meet ...

Viagra was approved by the U.S. Food and Drug Administration 27 years ago. Experts say it immediately changed the way we talk ...

The fourth pair of denosumab biosimilars, Conexxence and Bomyntra, are expected to launch in the United States in mid 2025, ...

Regulatory and reimbursement pathways should consider indirect benefits in addition to direct health benefits when evaluating ...

Humacyte's stock struggles despite FDA approval for Symvess, with financial concerns and slow adoption impacting future ...

A Durham biotechnology company has seen its stock price plummet over the past few days amid a stock offering and a media ...

Artrya (ASX:AYA) is the latest Aussie biotech stock to score an FDA approval and consequent rewarding share price jump from ...

The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...